化合物Bevenopran T14551

Product Introduction
Bioactivity


英文名: Bevenopran

描述: Bevenopran (CB-5945) is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.

体内活性: Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 120 mg/mL (310.53 mM)


关键字: Inhibitor | ADL 5945 | Bevenopran | CB 5945 | inhibit | ADL5945 | Opioid Receptor | CB5945

相关产品: ADL-5747 | ML-335 | Adrenorphin | Dermorphin | GR 89696 fumarate | Sideritoflavone | Neuropeptide AF (human) acetate | Ac-RYYRWK-NH2 acetate | μ opioid receptor agonist 3 | beta-Neoendorphin acetate(77739-21-0 free base)

相关库: Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Neurotransmitter Receptor Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Neuronal Signaling Compound Library | Inhibitor Library | GPCR Compound Library | Anti-Cancer Clinical Compound Library

化合物Bevenopran T14551信息由TargetMol中国为您提供，如您想了解更多关于化合物Bevenopran T14551报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途